This led Rakesh Jain to the elaboration of the “vessel normalization theory”, whereby treatment with an anti‐VEGF antibody (bevacizumab) normalizes the chaotic tumour blood vessel network, leading to increased drug delivery.39 This evidence concerns the gene VEGFA and neoplasm.